A First: Novartis AG Drug May Prevent Heart Attacks and Cut Lung Cancer Risk Too Post author:Sam Post published:August 27, 2017 Post category:BioPharma August 28, 2017By Alex Keown, BioSpace… Source: BioSpace You Might Also Like Incyte Release: Combination Of Epacadostat Plus Keytruda (Pembrolizumab) Demonstrates Activity In Clinical Trial Of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) June 4, 2017 GlycoMimetics Stock Takes Off on Positive Phase II Leukemia Data, Breakthrough Tag May 17, 2017 FDA Extends Review for Lipocine's TLANDO; Advisory Committee Meeting Date of January 10, 2018 Rem… November 16, 2017
Incyte Release: Combination Of Epacadostat Plus Keytruda (Pembrolizumab) Demonstrates Activity In Clinical Trial Of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) June 4, 2017
FDA Extends Review for Lipocine's TLANDO; Advisory Committee Meeting Date of January 10, 2018 Rem… November 16, 2017
